期刊文献+

高效液相色谱法测定人血浆中去铁酮含量

High Performance Liquid Chromatography Method for Determination of Deferiprone in Human Plasma
暂未订购
导出
摘要 目的 建立高效液相色谱法测定人血浆中去铁酮(DFP)含量.方法 Kromasil C18色谱柱(4.6 mm×200 mm,5 μm),流动相:乙腈-50 mmol·L-1磷酸二氢钾(含5 mmol·L-1庚烷磺酸钠,1%三乙胺)=11:89(用磷酸调至pH1.3),检测波长:278 nm,柱温:25 ℃,进样量:20 μL,流速:1 mL·min-1.结果 DFP在0.5~80.0 mg·L-1浓度范围内线性良好(r=0.996 5),最低检出浓度为0.5 mg·L-1.高、中、低3种浓度样品绝对回收率>85.6%,方法回收率>89.9%,日内精密度RSD在1.61%~3.70%,日间精密度RSD在1.84%~4.81%.结论 该方法操作简便易行,快速准确,灵敏度高,专属性强,适用于DFP的人体血浆浓度测定. Objective To establish a high performance liquid chromatography (HPLC) method for the determination ofdeferiprone in human plasma. Methods The analytical column was a Kromasil C18 column (4. 6 mm×200 mm, 5 μm). Themobile phase was a mixture of acetonitrile and buffer of 50 mmol·L-1 potassium dihydrogen phosphate (containing 5 mmol·L-1sodium heptanesulfonate and 1% triethylamine) (1189, pH adjusted to 1. 3 with phosphoric acid). Detection wave-length wasset at 278 nm. The column temperature was 25 ℃. The injected volume was 20 μ L. Flow rate was 1 mL·min-1 . Results Thecalibration curve of deferiprone were linear in the range of 0. 5-80. 0 mg·L-1(r =0. 996 5), and the lower limit of detection was0. 5 mg·L-1 . The absolute recoveries of deferiprone at low, medium and high concentrations were more than 85. 6%, and themethod recoveries were more than 89. 9%. The intraday coefficients of variation were 1. 61% - 3. 70%, and the interdaycoefficients of variation were 1. 84% -4. 81%. Conclusion The method is simple, quick, accurate, sensitive, and specific,and can be used in detecting deferiprone concentration in human plasma.
出处 《医药导报》 CAS 北大核心 2014年第2期164-167,共4页 Herald of Medicine
基金 广西科技厅自然科学基金面上项目(2012GXNSFAA053145) 广西卫生厅自筹经费科研课题(Z2011347)
关键词 去铁酮 人体血浆 色谱法 高效液相 含量测定去铁酮 人体血浆 色谱法 高效液相 含量测定 Deferiprone Human plasma High performance liquid chromatography Content determination
  • 相关文献

参考文献9

二级参考文献36

  • 1夏婷,方建培.去铁胺和deferiprone的临床研究进展[J].国外医学(儿科学分册),2005,32(1):40-42. 被引量:5
  • 2王长虹,邹小广,孙殿甲,王峥涛.盐酸去氢骆驼蓬碱血浆蛋白结合率的测定[J].中国医院药学杂志,2005,25(2):99-101. 被引量:8
  • 3薛永志,章国良,步秀云.氯桂丁胺对小鼠CYP450含量的影响及与大鼠血浆蛋白结合率[J].包头医学院学报,2005,21(4):339-341. 被引量:2
  • 4张蓓蓓,张尊建,田媛,汪洋,李先霞.洛索洛芬钠缓释片在比格犬体内的药代动力学[J].中国药科大学学报,2006,37(4):333-336. 被引量:5
  • 5Xu IJ, Jin L, Pan H, et al. Deferiprone protects the isolated atria from cardiotoxicity induced by doxorubicin [ J]. Acta Phannacologica Sinica,.2006, 27(10): 1333.
  • 6Fredenburg AM, Wedlund PJ, Skinner TL, et al. Phannacokinetlcs of representative 3-hydroxypyridin-4-ones in rabbits: CT20 and CP94[J]. Drug Metab Dispos, 1993, 21(2) : 255.
  • 7Mitchell K M, Dotson A L, Cool K M, et al. Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis [ J ]. Multi Scler, 2007, 13 ( 9 ) :1118-1126.
  • 8Angelucci E, Barosi G, Camaschella C, et al. Itahan Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders [ J ].Haematologica, 2008, 93 (5) : 741-752.
  • 9Liu P, Yao Y N, Wu S D, et al. The efficacy of deferiprone on tissues aluminum removal and copper, zinc, manganese level in rabbits[J]. J Inorg Biochem, 2005, 99(8) : 1733-1737.
  • 10Limenla L M, Jirasomprasert T, Tankanitlert J, et al. UGT1A6 genotype-related phannacokinetics of deferiprone (L1) in healthy volunteers[J].Bri J Clin Pharmacol, 2008, 65(5): 908-916.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部